Preferred Label : Infigratinib;

NCIt synonyms : 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-(6-((4-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)-1-methylurea;

NCIt definition : An orally bioavailable pan inhibitor of human fibroblast growth factor receptors (FGFRs) with potential antiangiogenic and antineoplastic activities. Infigratinib selectively binds to and inhibits the activities of FGFRs, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation, and the induction of tumor cell death. FGFRs are a family of receptor tyrosine kinases which may be upregulated in various tumor cell types and may be involved in tumor cell differentiation and proliferation, tumor angiogenesis, and tumor cell survival.;

UNII : A4055ME1VK;

InChIKey : QADPYRIHXKWUSV-UHFFFAOYSA-N;

CAS number : 872511-34-7; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 872511-34-7 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : BGJ-398;

ChEBI ID : CHEBI:63451;

Codes from synonyms : 272;

Details


Main resources

You can consult :


https://presse.inserm.fr/un-nouveau-traitement-entre-en-essai-clinique-chez-un-premier-enfant-achondroplase-en-france/42645
2021
false
false
false
France
French
scientific and technical information
achondroplasia
clinical trials as topic
child
france
Infigratinib
phenylurea compounds
pyrimidines
receptor, fibroblast growth factor, type 1
infigratinib

---
Nous contacter.
14/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.